Adicet Bio, Inc. Earnings Per Share, Basic and Diluted
Adicet Bio, Inc. (ACET) reported Earnings Per Share, Basic and Diluted of -$2.00 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-15
- Adicet Bio, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.47.
- Adicet Bio, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.44.
- Adicet Bio, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.34.
- Adicet Bio, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.82.
- Adicet Bio, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.00.
- Adicet Bio, Inc. earnings per share, basic and diluted for fiscal 2020 was -$5.01.
- Adicet Bio, Inc. earnings per share, basic and diluted for fiscal 2019 was -$13.15.
- Adicet Bio, Inc. earnings per share, basic and diluted for fiscal 2018 was -$4.78.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$1.25 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$2.00 10-K · filed 2022-03-15 | ||||
| 2021-09-30 | -$0.44 10-Q · filed 2021-11-10 | -$0.78 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.54 10-Q · filed 2021-11-10 | -$2.01 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||
| 2021-06-30 | -$0.34 10-Q · filed 2021-08-12 | -$1.11 10-Q · filed 2021-08-12 | -$1.59 derived: net income ÷ weighted average shares · filed 2022-08-10 | -$2.70 derived: net income ÷ weighted average shares · filed 2022-08-10 | ||||
| 2021-03-31 | -$0.82 10-Q · filed 2021-05-17 | -$1.32 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$2.65 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$4.02 derived: net income ÷ weighted average shares · filed 2022-05-12 | ||||
| 2020-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$1.91 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$3.56 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$5.01 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | -$2.84 10-Q · filed 2021-11-10 | -$6.29 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$8.69 10-Q · filed 2021-11-10 | -$11.72 derived: net income ÷ weighted average shares · filed 2021-11-10 | ||||
| 2020-06-30 | -$3.88 10-Q · filed 2021-08-12 | -$0.15 10-Q · filed 2020-07-30 | -$5.96 10-Q · filed 2021-08-12 | -$0.35 10-Q · filed 2020-07-30 | -$9.01 derived: net income ÷ weighted average shares · filed 2021-08-12 | -$15.87 derived: net income ÷ weighted average shares · filed 2021-08-12 | ||
| 2020-03-31 | -$2.07 10-Q · filed 2021-05-17 | -$0.19 10-Q · filed 2020-05-07 | -$5.12 derived: net income ÷ weighted average shares · filed 2021-05-17 | -$11.99 derived: net income ÷ weighted average shares · filed 2021-05-17 | ||||
| 2019-12-31 | -$0.79 10-K · filed 2020-03-12 | -$9.92 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$13.15 10-K · filed 2021-03-12 | -$2.41 10-K · filed 2020-03-12 | ||||
| 2019-09-30 | -$6.87 10-Q · filed 2020-11-05 | -$0.68 10-Q · filed 2019-11-05 | -$10.10 10-Q · filed 2020-11-05 | -$1.51 10-Q · filed 2019-11-05 | ||||
| 2019-06-30 | -$0.51 10-Q · filed 2020-07-30 | -$0.91 10-Q · filed 2020-07-30 | ||||||
| 2019-03-31 | -$0.38 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | -$0.21 10-K · filed 2020-03-12 | $0.68 derived: net income ÷ weighted average shares · filed 2021-03-12 | $6.03 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$4.78 10-K · filed 2021-03-12 | -$1.42 10-K · filed 2019-03-18 | |||
| 2018-09-30 | -$0.30 10-K · filed 2020-03-12 | -$0.78 derived: net income ÷ weighted average shares · filed 2019-11-05 | -$1.23 10-Q · filed 2019-11-05 | -$2.67 derived: net income ÷ weighted average shares · filed 2020-03-12 | ||||
| 2018-06-30 | -$0.48 10-K · filed 2020-03-12 | -$0.95 10-Q · filed 2019-08-14 | -$2.58 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$3.41 derived: net income ÷ weighted average shares · filed 2020-03-12 | ||||
| 2018-03-31 | -$0.46 10-K · filed 2020-03-12 | -$2.53 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$3.57 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$4.64 derived: net income ÷ weighted average shares · filed 2020-03-12 | ||||
| 2017-12-31 | -$5.11 10-K · filed 2019-03-18 | -$5.91 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$6.90 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$8.42 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$0.75 10-K · filed 2019-03-18 | -$1.69 derived: net income ÷ weighted average shares · filed 2019-03-18 | -$2.79 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | -$0.94 10-K · filed 2019-03-18 | -$2.09 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$1.20 10-K · filed 2019-03-18 | |||||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |